ulin (TM) (1, 5, 6) , von Willebrand factor (vWF) (1, 2, 7) , tissue factor (TF) (8, 9) , and tissue factor pathway inhibitor (TFPI) (9, 10) have been repeatedly found in HD patients.
We studied the relationships between predialysis plasma levels of TM, vWF, TF and TFPI, and then observed the effects of the HD procedure on the markers. We aimed to determine whether and to what extent the HD treatment affects blood levels of these endothelium-derived substances. During the preceding month, none of the participants had suffered from any inflammatory or infectious diseases, hemostatic disorders, received blood transfusion or medications known to affect hemostasis (except of heparin during HD procedures). Fifteen age-and sex-matched healthy volunteers served as a control group for hemostatic studies.
Approval of our institutional ethical board was obtained and all patients and controls gave their informed consent.
Methods
Fasting blood was drawn into 3.8% trisodium citrate (9:1) from the arteriovenous fistula before heparinization and onset of HD, and again after dialysis. Cell-free plasma was prepared conventionally, aliquoted, and stored at -40°C until further assay.
Plasma levels of soluble antigens of TM, TF, and TFPI were measured in duplicates using enzyme-linked immunosorbent assay (ELISA) and kits purchased from American Diagnostica Inc (Greenwich, CT). Plasma vWF levels were determined using the ELISA kit from Diagnostica Stago (Asnieres-sur-Seine, France). To minimalize the influence of hemoconcentration, the postdialysis values were corrected using the following formula (11) Fig. 1 ) when adjusted for each other. There were no correlations between A TFPI and the dose of enoxaparin, duration of HD session, and delivered dose of dialysis (data not shown).
DISCUSSION
This study shows that pre-dialysis plasma levels of endothelial markers such as TM, vWF, TF, and TFPI are increased in uremic patients. It also shows that the HD procedure results only in increased TFPI levels, and that the increase depends on the over-dialytic decrease in blood pressure and the surface area of the bioincompatible dialysis membrane.
Tissue factor is a cell surface receptor and a principal initiator of the extrinsic pathway of blood coagulation. It is exposed in the subendothelial tissue following disruption of the endothelial lining, and subsequently released into the circulation (8,9) . On the other hand, the injured endothelial cells also release TFPI, which inhibits activity of a procoagulant TF/VIIa/Xa complex (12) .
In our study, the pre-dialysis TF and TFPI levels were directly associated with endothelial cell damage or activation markers such as vWF and TM. Both TF and TM directly correlated with alanine aminotransferase, which confirms the recently described role of liver dysfunction in their metabolism in HD patients (5, 6, 13) . A HD session resulted in a further increase in plasma TFPI concentration. This concurs with results of previous reports (10, 14) showing a continuous increase of TFPI during HD, especially in response to heparin injection. Heparin is a potent stimulant of the release of TFPI from endothelial cells (15) . Taking into account the possibly different effects of unfractionated and LMWH on the vascular endothelium in maintenance HD patients (5, 12) , we studied only patients anticoagulated with enoxaparin. Nevertheless, there was no association between post-dialysis TFPI levels and the dose of enoxaparin. To exclude the influence of different types of dialysis membrane on endothelial acti-vation in HD patients (16) , only modified cellulose membranes were used.
We observed a close association between the increase in TFPI and the surface area of the dialysis membrane. It is plausible that the direct contact of blood cells with the bioincompatible membrane in the extracorporeal circuit leads to release of TFPI from platelets being a rich source of the factor (12). However, there was no correlation between TFPI and platelet counts in our patients. On the other hand, activation of leukocytes and platelets, and enhanced lipid oxidation during HD procedures have been hypothesized to contribute to the activation or damage of endothelial cells (16, 17) . In this study, the increment in TFPI was especially pronounced in patients with a marked over-dialytic decrease in blood pressure. There are data demonstrating poor associations between changes of blood pressure and those of body weight (18) . This finding has been used as an argument against the only role of intravascular fluid volume in regulation of blood pressure during HD, and in support of the involvement of the other vasoactive substances, including potent nitric oxide (19) .
In general, vascular endothelial cells are activated by hemodynamic forces such as pulsatile blood flow, changes in hydrostatic pressure, cyclic strain, and shear stress (20) . All these are likely to operate during a HD procedure. The link between post-dialytic hypotension and activation of the endothelium was proved by excessive generation of nitric oxide during HD (19) . The significant increase in TFPI being associated with falling blood pressure in this study provides further evidence of the ongoing endothelial activation during HD. However, we are unable to explain why a low blood pressure is such a specific stimulus for the release of TFPI, but not for the other endothelial markers. Nevertheless, this phenomenon seems to be of interest in view of the recently established role of low post-dialysis blood pressure as a strong predictor of increased cardiovascular mortality in HD patients (21, 22) . Hypothetically, the release of TFPI in response to falling blood pressure may represent a part of the countersystem against the hypotension-induced prothrombotic state.
In conclusion, enhanced release of TFPI during HD may be due to a direct contact of blood with artificial membrane and disturbed hemodynamic conditions, both being important activators of the endothelial cells.
